Sign In
Buy ALLO
$2.00
-0.0500 (-2.44%)
At Close: Jun 03, 2026
3 Hot Penny Stocks to Buy With $1000
07:55am, Saturday, 07'th Sep 2024
Penny stocks are some of my favorite stocks to watch.
Allogene Therapeutics (ALLO) Up 6.4% Since Last Earnings Report: Can It Continue?
12:37pm, Friday, 06'th Sep 2024
Allogene Therapeutics (ALLO) reported earnings 30 days ago. What's next for the stock?
Allogene Therapeutics: Cema-Cel Promising Among Innovative CAR T-Cell Therapies
11:39pm, Monday, 26'th Aug 2024
Allogene Therapeutics is a clinical-stage biotech developing allogeneic CAR T therapies for cancer and autoimmune diseases, with a focus on Cema-cel for LBCL. ALLO's advanced gene-editing platforms, l
Allogene Therapeutics, Inc. (ALLO) Q2 2024 Earnings Call Transcript
12:34am, Saturday, 10'th Aug 2024
Allogene Therapeutics, Inc. (NASDAQ:ALLO ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Christine Cassiano - Executive Vice President, Chief Corporate Officer and IR
Allogene (ALLO) Posts Narrower Than Expected Loss in Q2
10:51am, Thursday, 08'th Aug 2024
Allogene's (ALLO) second-quarter earnings beat estimates but sales miss the mark. It expects to submit a regulatory filing with the FDA for its lead pipeline drug in large B-cell lymphoma indication b
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
08:30am, Thursday, 08'th Aug 2024
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCA
7 Biotech Stocks to Buy for Their Game-Changing Potential
06:00am, Thursday, 08'th Aug 2024
With the market struggling amid rising recession fears, now may be the ideal time to consider biotech stocks. First, the sector itself is a financially lucrative one.
Allogene Therapeutics Reports Second Quarter 2024 Financial Results and Business Update
04:02pm, Wednesday, 07'th Aug 2024
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloC
Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update
08:30am, Wednesday, 31'st Jul 2024
SOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloC
SOUTH SAN FRANCISCO, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR
SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., June 20, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of alloge
Allogene: Two End Of 2024 Data Readouts With Improved Allogeneic CAR-T Products
01:09pm, Wednesday, 12'th Jun 2024
Allogene Therapeutics, Inc. initiation of phase 2 ALPHA3 study, using cema-cel for the treatment of patients with 1st-line large B-cell lymphoma, expected in mid-2024 with two data analysis in 2026. R
If You Can Only Buy One Penny Stock in May, It Better Be One of These 3 Names
04:05pm, Tuesday, 28'th May 2024
Penny stocks carry a great deal of risk. It's why investors are often told to steer clear of them.
Insider Buying of These 6 Stocks Surges: Fracking, Boats, a Buyout Candidate
09:15am, Sunday, 26'th May 2024
With the earnings-reporting season winding down, the windows for making insider purchases are opening up.
Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
08:30am, Thursday, 23'rd May 2024
SOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR
